维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Aisner D"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	BRAFV600E突变的上皮样胶质母细胞瘤BRAFVE1免疫表达形式显示文摘上皮样胶质母细胞瘤(E-GBMs)的BRAFV600E突变率可高达50%以上,而普通型GBMs突变率很低,提示E-GBMs最可能为GBMs的一种变异亚型。BRAF基因状态检测是决定靶向药物vemurafenib使用的重要依据。采用BRAFVE1免疫组化(IHC)检测是否可以替代Sanger测序目前尚不清楚。	Kleinschmidt-DeMasters B K Aisner D L Foreman N K 康锶鹏余英豪	2015	临床与实验病理学杂志2015，31，11：	14
2	Lymphocytotoxic antibody is a predictor of response to random doner platelet treasfusion显示文摘	HOGGE D E DUTCHER J R AISNER J	1983	Am J Hematol1983，14，4：	1
3	Molecular Pathology of Non-Small Cell Lung Cancer A Practical Guide显示文摘	Aisner D L Marshall C B	2012	american journal of clinical pathology2012，138，3：	1
4	Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic nonsmall cell lung cancer显示文摘	Aisner J Hiponia D	1995	Semin Oncol1995，22，49：	1
5	Mechanismsof resistance to crizotinib in patients with ALK generearranged non-small cell lung cancer 显示文摘	Doebele R C Pilling A B Aisner D L	2012	Clin CancerRes2012，18，5：	1
6	Paclitaxel and carboplatin with concurrent thoracic radiotherapy for regionally advanced non-small-cell cancer (NSCLC)(Meeting Abstr)显示文摘	Belani CP Aisner J Hiponia D	1996	Proc Ann Meet Am Soc Clin Oncol1996，15，：	1
7	An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity 显示文摘	Yi X White D M Aisner D L	2000	Neoplasia2000，2，5：	1
8	An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity显示文摘	Yi X white D M Aisner D L	2000	Neoplasia2000，2，5：	1
9	An ahernate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity 显示文摘	Yi X White D M Aisner D L	2000	Neoplasia2000，2，5：	1
10	Diagnostic assays for identification of anaplastic lymphoma kinase - positive non - small cell lung cancer显示文摘	Weickhardt A J Aisner D L Franklin W A	2013	Cancer2013，119，8：	1
11	Combined modalities in the treatment of head and neck cancers显示文摘	Aisner J Hiponia D Conley B	1995	Semin Oncol1995，22，36：	1
12	Functional requirement of p23 and Hsp90 in telomerase complexes显示文摘	Holt S E Aisner D L Baur J	1999	Genes Dev1999，13，：	1
13	EST 2582 phase U trial of Cisplatin in metastatic or recurrent thymoma显示文摘	Bonomi PD Finkelstein D Aisner S	1993	Am J Clin Oncol1993，16，6：	1
14	Paclitaxel and carboplatin with concurrent thoracic radiotherapy for regionally advanced non-small-cell cancer (NSCLC)(Meeting Abstr)显示文摘	Belani CP Aisner J Hiponia D	1996	Proc Ann Meet Am Soc Clin Oncol1996，15，：	1
15	EST 2582 phase Ⅱ trial of cisplatin in metastatic or recurrent thymoma显示文摘	Bonomi PD Finkelstein D Aisner S	1993	Am J Clin Oncol1993，16，：	1
16	Paclitaxel and carboplatin with concurrent thoracic radiotherapy for regionally advanced non- small cell lung cancer(NSCLC)显示文摘	Aisner J Hiponia D	1996	Proc Ann Meet Am Soc Clin Oncol1996，15，：	1
17	显示文摘	Ouellette M Aisner D SavreTrain I	1999	Biochem Biophys Res Commun1999，254，3：	1
18	Paclitaxel and carboplatin inmetastatic non-small cell lung cancer:preliminary results of a phase Istudy显示文摘	Belani CP Aisner J Hiponia D	1996	Semin Oncol1996，23，512：	1
19	Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung eaneer显示文摘	Doebele R C Pilling A B Aisner D L	2012	Clin Cancer Res2012，18，5：	1
20	Paclitaxel and carboplatin with concurrent thoracic radiotherapy for regionally advanced non-small-cell cancer(NSCLC)显示文摘	Belani CP Aisner J Hiponia D	1996	Proc Ann Meet Am Soc Clin Oncol1996，15，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示